|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/51 | |
| A61K 35/28 | |||
| A61P 37/00 | |||
| A61K 38/19 |
| (11) | Patento numeris | 3054961 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14851547.1 |
| Europos patento paraiškos padavimo data | 2014-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2014/050887 |
| Data | 2014-10-07 |
| (87) | Numeris | WO 2015/052716 |
| Data | 2015-04-16 |
| (30) | Numeris | Data | Šalis |
| 201361888713 P | 2013-10-09 | US |
| (72) |
YARKONI, Shai, IL
|
| (73) |
Cellect Biotherapeutics Ltd.,
23 Hata`as Street 3rd Floor, Kfar Saba 4442510,
IL
|
| (54) | ACTIVATION OF HEMATOPOIETIC PROGENITORS BY PRETRANSPLANT EXPOSURE TO DEATH LIGANDS |
| ACTIVATION OF HEMATOPOIETIC PROGENITORS BY PRETRANSPLANT EXPOSURE TO DEATH LIGANDS |